Innovent Biologics Inc. (IVBXF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.72
    0.34 (2.75%)
    At close: Oct 03, 2025, 1:56 PM
    12.50
    -1.73%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    Innovent Biologics Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.42B 6.21B 4.56B 4.27B
    Cost of Revenue
    		 1.51B 1.81B 930.99M 573.04M
    Gross Profit
    		 7.91B 4.4B 3.63B 3.7B
    Operating Income
    		 -755.87M -1.68B -3.12B -2.7B
    Interest Income
    		 423.45M 452.84M 189.54M 151.75M
    Pretax Income
    		 -78.62M -1.14B -2.17B -2.64B
    Net Income
    		 -94.63M -1.03B -2.18B -2.73B
    Selling & General & Admin
    		 5.08B 3.85B 3.43B 3.61B
    Research & Development
    		 2.68B 2.23B 2.87B 2.48B
    Other Expenses
    		 -112.45M n/a -90.2M -341.6M
    Operating Expenses
    		 7.65B 6.08B 6.21B 5.75B
    Interest Expense
    		 67.65M 98.62M 101.7M 62.46M
    Selling & Marketing Expenses
    		 4.35B 3.1B 2.59B 2.62B
    Cost & Expenses
    		 9.16B 7.89B 7.68B 6.97B
    Income Tax Expense
    		 16.01M -116.5M 8.8M 87.04M
    Shares Outstanding (Basic)
    		 1.58B 1.56B 1.49B 1.45B
    Shares Outstanding (Diluted)
    		 1.63B 1.56B 1.49B 1.46B
    EPS (Basic)
    		 -0.06 -0.66 -1.46 -1.88
    EPS (Diluted)
    		 -0.06 -0.66 -1.46 -1.88
    EBITDA
    		 -480.28M -660.68M -1.75B -2.37B
    EBIT
    		 -755.87M -1.05B -2.07B -2.58B
    Depreciation & Amortization
    		 275.6M 385.1M 319.42M 204.75M

    Add to Watchlist